We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00757250
Recruitment Status : Terminated (Difficulty recruiting subjects to dosing cohort 5.)
First Posted : September 23, 2008
Last Update Posted : February 29, 2012
Tarix Pharmaceuticals
Information provided by (Responsible Party):
US Biotest, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2011
  Study Completion Date : December 2011